文献
J-GLOBAL ID:202202256244782894
整理番号:22A0232659
ジヒドロアルテミシニンは血液から胆汁へのコレステロールおよび胆汁酸のベクター輸送を増強することにより卵巣切除マウスにおける高コレステロール血症を改善する【JST・京大機械翻訳】
Dihydroartemisinin improves hypercholesterolemia in ovariectomized mice via enhancing vectorial transport of cholesterol and bile acids from blood to bile
著者 (45件):
Lei Zili
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Lei Zili
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Lei Zili
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Wu Huijuan
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Wu Huijuan
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Wu Huijuan
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Wu Huijuan
(School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Center, Guangzhou 510006, PR China)
,
Yang Yanhong
(The First Affiliated Hospital (School of Clinical Medicine), Guangdong Pharmaceutical University, Nong-Lin-Xia Road 19#, Yue-Xiu District, Guangzhou 510080, PR China)
,
Hu Qing
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Hu Qing
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Hu Qing
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Lei Yuting
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Lei Yuting
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Lei Yuting
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Liu Wanwan
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Liu Wanwan
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Liu Wanwan
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Nie Ya
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Nie Ya
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Nie Ya
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Nie Ya
(School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Center, Guangzhou 510006, PR China)
,
Yang Lanxiang
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Yang Lanxiang
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Yang Lanxiang
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Yang Lanxiang
(School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Center, Guangzhou 510006, PR China)
,
Zhang Xueying
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Zhang Xueying
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Zhang Xueying
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Zhang Xueying
(School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Center, Guangzhou 510006, PR China)
,
Yang Changyuan
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Yang Changyuan
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Yang Changyuan
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Yang Changyuan
(School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Center, Guangzhou 510006, PR China)
,
Lin Ting
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Lin Ting
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Lin Ting
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Tong Fengxue
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Tong Fengxue
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Tong Fengxue
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Zhu Jiamin
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Zhu Jiamin
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Zhu Jiamin
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
,
Guo Jiao
(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases...)
,
Guo Jiao
(Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, PR China)
,
Guo Jiao
(Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, PR China)
資料名:
Bioorganic & Medicinal Chemistry
(Bioorganic & Medicinal Chemistry)
巻:
53
ページ:
Null
発行年:
2022年
JST資料番号:
W0556A
ISSN:
0968-0896
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)